REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Neo Limitada (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Scientific Research and Development Services
Full name: Laboratorios Neo Limitada Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

porto bianco laboratório farmacêutico is a Colombian pharmaceutical company with 1-10 employees, focused on drug research and production to improve the quality of life.

Headquarters
Cl 5 B # 25 - 91
Cali; Valle del Cauca;

Contact Details: Purchase the Laboratorios Neo Limitada report to view the information.

Website: http://www.laboratoriosneo.com

Basic Information
Total Employees:
Purchase the Laboratorios Neo Limitada report to view the information.
Outstanding Shares:
Purchase the Laboratorios Neo Limitada report to view the information.
Registered Capital:
Purchase the Laboratorios Neo Limitada report to view the information.
Incorporation Date:
December 16, 1969
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
99.67%
Purchase this report to view the information.
0.33%
Company Performance
Financial values in the chart are available after Laboratorios Neo Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
3.9%▲
Total operating revenue
3.41%▲
Operating profit (EBIT)
-35.83%▼
EBITDA
-19.47%▼
Net Profit (Loss) for the Period
-9.13%▼
Total assets
10.31%▲
Total equity
6.05%▲
Operating Profit Margin (ROS)
-2.95%▼
Net Profit Margin
-0.36%▼
Return on Equity (ROE)
-0.95%▼
Debt to Equity Ratio
-0.06%▼
Quick Ratio
-0.16%▼
Cash Ratio
0.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo